Who owns INO?
Institutional ownership of Inovio Pharmaceuticals Inc. from Form 13F, Q2 2026
102 institutional managers reported holding Inovio Pharmaceuticals Inc. (INO) in Form 13F filings for Q2 2026, with 32,810,008 shares worth $36.1M. The largest reported holder was FMR LLC. Managers that filed both quarters cut a net 417,498 shares (-1.5%). 21 opened new positions and 19 sold out.
- Funds holding
- 102
- Value held
- $36.1M
- New / sold out
- 21 / 19
- Net shares, same filers
- -1.5%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of INO
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| FMR LLC | $9.3M | 25.8% | 8,454,797 | Trimmed |
| Jupiter Topco LLC | $5.7M | 15.8% | 5,171,053 | First report |
| Vanguard Capital Management LLC | $4.0M | 11.1% | 3,650,562 | Added |
| Boxer Capital Management, LLC | $3.1M | 8.7% | 2,844,994 | Added |
| ADAR1 Capital Management, LLC | $2.4M | 6.5% | 2,143,910 | Added |
| D. E. Shaw & Co., Inc. | $1.5M | 4.1% | 1,351,656 | Trimmed |
| Two Sigma Investments, LP | $1.4M | 3.8% | 1,239,778 | Added |
| Eversept Partners, LP | $1.1M | 3.2% | 1,035,360 | Unchanged |
| Geode Capital Management, LLC | $884K | 2.4% | 802,751 | Added |
| Millennium Management LLC | $876K | 2.4% | 796,107 | Trimmed |
| BlackRock, Inc. | $857K | 2.4% | 779,057 | Added |
| Vanguard Fiduciary Trust Co | $529K | 1.5% | 480,769 | Added |
| Caption Management, LLC | $527K | 1.5% | 478,950 | New |
| Renaissance Technologies LLC | $397K | 1.1% | 361,339 | Trimmed |
| State Street Corp | $370K | 1.0% | 336,610 | Added |
| Gsa Capital Partners LLP | $292K | 0.8% | 265,011 | Unchanged |
| UBS Group AG | $289K | 0.8% | 262,320 | Added |
| Quadrature Capital Ltd | $285K | 0.8% | 258,928 | New |
| Citadel Advisors LLC | $266K | 0.7% | 241,775 | Trimmed |
| Northern Trust Corp | $192K | 0.5% | 174,394 | Trimmed |
| Bridgeway Capital Management, LLC | $190K | 0.5% | 173,000 | Unchanged |
| Nomura Holdings Inc | $165K | 0.5% | 150,000 | New |
| HRT Financial LP | $154K | 0.4% | 140,432 | Added |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $147K | 0.4% | 133,648 | New |
| GMT Capital Corp | $139K | 0.4% | 126,119 | Unchanged |
Share of 13F holdings is each fund's shares as a share of the 32,810,008 INO shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Two Sigma Investments, LP Added+$934K
- Vanguard Capital Management LLC Added+$824K
- ADAR1 Capital Management, LLC Added+$741K
- Caption Management, LLC New+$527K
- Boxer Capital Management, LLC Added+$522K
- Quadrature Capital Ltd New+$285K
- Nomura Holdings Inc New+$165K
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main New+$147K
- HRT Financial LP Added+$140K
- BlackRock, Inc. Added+$129K
Biggest sellers in Q2 2026
- Adage Capital Partners GP, L.l.c. Sold out-$1.4M
- Diadema Partners LP Sold out-$979K
- FMR LLC Trimmed-$973K
- D. E. Shaw & Co., Inc. Trimmed-$947K
- Millennium Management LLC Trimmed-$676K
- 683 Capital Management, LLC Sold out-$433K
- Renaissance Technologies LLC Trimmed-$311K
- Persistent Asset Partners Ltd Sold out-$247K
- Northern Trust Corp Trimmed-$137K
- XTX Topco Ltd Trimmed-$118K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $5.0M and sold $6.8M; 27 added and 14 trimmed.
Schedule 13D and 13G filings on INO
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-17ADAR1 Capital Management, LLC SCHEDULE 13G filed by Inovio Pharmaceuticals Inc.Schedule 13G
- 2025-12-05FMR LLC SCHEDULE 13G filed by Inovio Pharmaceuticals Inc.Schedule 13G
- 2025-11-14JANUS HENDERSON GROUP PLC SCHEDULE 13G filed by Janus Henderson Group plcSchedule 13G
- 2025-04-30VANGUARD GROUP INC SCHEDULE 13G filed by Inovio Pharmaceuticals Inc.Schedule 13G
- 2025-02-10HIGHBRIDGE CAPITAL MANAGEMENT LLC SCHEDULE 13G filed by Inovio Pharmaceuticals Inc.Schedule 13G
Questions about INO ownership
- Who owns INO stock?
- 102 institutional investment managers reported INO positions in their Form 13F filings for Q2 2026, holding 32,810,008 shares worth $36.1M in total. FMR LLC reported the largest position.
- Are funds buying or selling INO?
- In Q2 2026, 21 managers opened new INO positions, 27 added, 14 trimmed and 19 sold out. Managers that filed in both quarters sold a net 417,498 shares.
- How current is this INO institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to INO by CUSIP. Options are left out. INO news and filings · INO insider trades · Top funds